Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

Lipid-based nanocarriers have been extensively investigated for their application in drug
delivery. Particularly, liposomes are now clinically established for treating various diseases …

Despite significant advances in understanding breast cancer pathogenesis and prognosis, it
remains one of the most common causes of death for women worldwide. To develop a more …

The excessive inappropriate use of systemic antibiotics has contributed to the emergence of
antibiotic-resistant pathogens, which pose a significant risk to the success of treatment. This …

Extracellular vesicles (EVs) are nanoparticles released from various cell types that have
emerged as powerful new therapeutic option for a variety of diseases. EVs are involved in …

Simple Summary Despite the availability of numerous therapeutic approaches, pancreatic
ductal adenocarcinoma still stands as one of the most fatal cancers worldwide …

Chitosan-decorated liposomes were proposed for the first time for the intranasal delivery of
acetylcholinesterase (AChE) reactivator pralidoxime chloride (2-PAM) to the brain as a …

The growing need for innovative drug delivery systems has led to extensive research to
address the limitations associated with conventional dosage forms. Lipid nanoparticles have …